SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is attracting significant investor attention ahead of its quarterly report, with the community actively debating whether the stock's recent valuation surge and strong revenue backlog will be enough to outweigh potential concerns regarding Neutron launch timelines and profitability. Traders are expressing mixed sentiment, with some highlighting high-conviction long-term growth prospects and new contract wins, while others are hedging with bearish positions due to sensitivity over earnings execution and market volatility.

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Riot Platforms is surging after signing a 20-year, $9.1 billion data center lease with Anthropic, a move the community views as a major strategic pivot toward AI infrastructure. While some investors remain skeptical of past management execution and potential volatility, many are bullish on the company's ability to monetize its power capacity as a key player in the AI buildout.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending as investors weigh strong subscriber and revenue growth against margin compression and ongoing regulatory scrutiny ahead of the upcoming earnings release. The community remains deeply divided, with bulls pointing to the company's aggressive international expansion and potential for AI-driven service integration, while bears highlight EPS misses and high acquisition costs as significant risks.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing high engagement as investors weigh the company's long-term potential against concerns over quarterly financial performance and satellite launch execution. Community sentiment remains deeply divided, with bulls highlighting the massive $1.3B backlog and government contract wins while bears express skepticism regarding high cash burn and the consistency of the launch cadence.

Coherent Corp. engages in the development, refinement, manufacturing, and marketing of engineered materials, opto-electronic components and devices, and lasers for use in the industrial, communications, electronics, and instrumentation markets. It operates through the following segments: Networking, Materials, and Lasers. The Networking segment leverages compound semiconductor technology platforms and deep knowledge of end-user applications. The Materials segment markets engineered materials and optoelectronic devices. The Lasers segment serves industrial customers in semiconductor capital equipment, display capital equipment, precision manufacturing, and aerospace and defense, as well as instrumentation customers in life sciences and scientific research. The company was founded by Carl J. Johnson in 1971 and is headquartered in Saxonburg, PA.

Coherent Corp

Coherent Corp is experiencing significant price volatility ahead of its upcoming earnings report, with the community divided between investors holding for long-term AI optical infrastructure growth and active traders attempting to navigate aggressive swings. The stock's recent pullback is being debated as either a healthy profit-taking reset within a structural AI bull cycle or a deeper technical warning signal.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is experiencing significant market volatility driven by institutional call flow and polarizing debates over its vehicle-market economics versus allegations of accounting irregularities. Investors are closely monitoring upcoming earnings and legal developments, as community sentiment remains deeply divided between those betting on a short squeeze and those convinced the stock is fundamentally overvalued.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending following the announcement of a strategic agreement to acquire Wisk Aero, SkyGrid, and Insitu from Boeing, a deal that integrates profitable defense revenue and advanced autonomous flight technology into Archer's operations. The community is actively debating the implications of this expansion, weighing the long-term potential of the diversified aerospace platform against concerns regarding share dilution and the company's ongoing capital requirements.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

Markets are showing heightened volatility as investors weigh the Federal Reserve's interest rate path, persistent geopolitical tensions in the Middle East, and mixed corporate earnings results. The community is actively debating the sustainability of the AI sector's massive capital expenditure while closely monitoring labor data for clues on the potential for future policy shifts.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is currently trending due to a surge in positive sentiment and trading volume following the announcement of successful Phase 2 trial results for its lead asset, ABCL635. The community is actively discussing the stock's potential re-rating as a pharma-focused entity, with many investors highlighting strong analyst upgrades, significant institutional interest, and the perceived validation of the company's proprietary drug discovery platform.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is facing significant volatility as investors weigh the stock's recent decline against uncertainty surrounding the broader sports betting sector and upcoming quarterly earnings. While some community members remain bullish on the long-term potential of the company's new prediction markets and upcoming NFL season, others are actively debating the impact of increased competition and concerns over management's ability to drive consistent growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TNXP is moving higher after reporting strong Q2 2026 earnings, with total revenue of $13.54M (up 577.88% YoY) and TONMYA net sales of approximately $11M, up 197% quarter-over-quarter, both beating analyst consensus estimates. The earnings report also highlighted significant commercial traction for TONMYA, including 12,592 total prescriptions (+100% QoQ), a 207% increase in refills, and expanding payer coverage to 136 million lives, with traders focusing on the large short interest (~25% of float) and days-to-cover as potential squeeze catalysts.

Why Is TNXP Stock Rising Today?

Equity

Tonix announced a second commercial payer agreement for Tonmya, its fibromyalgia treatment.

Tonix Shares Jump After Landing Second Commercial Payer Agreement For TONMYA

Tonix Pharmaceuticals Holding shares are trading higher Monday after securing second commercial payer agreement for fibromyalgia drug TONMYA.read more...

TNXP Stock Climbs 7%: Retail Bets On $30M Revenue Upside From Tonmya Deal

The company announced a new agreement with a major group purchasing organization which opens coverage for its Tonmya drug to roughly 35 million commercially insured patients in the U.S.

Why Tonix Pharmaceuticals Shares Are Rallying Wednesday

Tonix Pharmaceuticals Holding shares are trading higher Wednesday after announcing commercial payer coverage for fibromyalgia drug TONMYA.read more...

Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Rating Upgraded by TD Cowen

TD Cowen raised Tonix Pharmaceuticals to a "strong-buy" rating in a report on Tuesday...

Tonix Pharmaceuticals (TNXP) to Release Quarterly Earnings on Monday

Tonix Pharmaceuticals (NASDAQ:TNXP) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-tonix-pharmaceuticals-holding-corp-stock...

TNXP Slips After Hours On Slower Than Expected Launch For Fibromyalgia Drug

The company said on Friday that it now expects a net loss for the first quarter of about $40.8 million compared to a loss of $16.8 million for the corresponding quarter of 2025.

Wall Street Zen Downgrades Tonix Pharmaceuticals (NASDAQ:TNXP) to Sell

Wall Street Zen cut shares of Tonix Pharmaceuticals from a "hold" rating to a "sell" rating in a research report on Sunday...

Tonix Pharmaceuticals (NASDAQ:TNXP) Upgraded by Wall Street Zen to "Hold" Rating

Wall Street Zen upgraded shares of Tonix Pharmaceuticals from a "sell" rating to a "hold" rating in a research note on Saturday...

Tonix Pharmaceuticals Stock Hits New 52-Week Low: What's Driving The Action?

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower Monday morning, hitting a fresh 52-week low as investors weigh a new SEC filing alongside a biotech pipeline update from...

$TNXP Q2 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of -$2.44 up 36.79% YoY
• Reported revenue of $13.54M up 577.88% YoY

Stocktwits

Tonix Pharmaceuticals Holding Corp

 Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of -$2.44 up 36.79% YoY
• Reported revenue of $13.54M up 577.88% YoY

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

$TNXP Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of -$2.44 up 36.79% YoY
• Reported revenue of $13.54M up 577.88% YoY

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$12.59
Prev Close	$12.03
Open	$11.62
Dividend Yield	0.00%
50-Day Moving Average	$11.63
Beta	1.44
Avg. Volume	503,787.09
PE Ratio	-0.88

52-Week High	$69.97
52-Week Low	$9.40
Market Capitalization	$191.77M
EPS (Annual)	-$14.57
Price to Book	0.79
Revenue Per Employee	$92,302.82

Feed

News

Sentiment

Earnings

Fundamentals

Info